Limor Zur-Stoller
No más puestos en curso
Perfil
Limor Zur-Stoller served as Vice President-Finance & Investor Relations at RadView Software Ltd.
She was also Chief Financial Officer & Treasurer at Gammacan International, Inc. from 2008 to 2011.
From 2008 to 2010, she held the position of Vice President-Finance at Rosetta Genomics Ltd.
Later, she served as Chief Financial Officer & IR Contact at G.F.C Green Fields Capital Ltd.
from 2012 to 2015.
Zur-Stoller completed her undergraduate degree from Tel-Aviv University.
Antiguos cargos conocidos de Limor Zur-Stoller.
| Empresas | Cargo | Fin |
|---|---|---|
| ROSETTA GENOMICS LTD. | Director Financiero/CFO | 01/10/2010 |
| G.F.C GREEN FIELDS CAPITAL LTD. | Director Financiero/CFO | - |
Gammacan International, Inc.
 Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Director Financiero/CFO | - |
| RADVIEW SOFTWARE LTD. | Director Financiero/CFO | - |
Formación de Limor Zur-Stoller.
| Tel-Aviv University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| RADVIEW SOFTWARE LTD. | Technology Services |
| ROSETTA GENOMICS LTD. | Health Technology |
| G.F.C GREEN FIELDS CAPITAL LTD. | Finance |
| Empresas privadas | 1 |
|---|---|
Gammacan International, Inc.
Gammacan International, Inc. Medical SpecialtiesHealth Technology Gammacan International, Inc. operates as a life sciences company. The company focuses on the development of immunotherapy and related approaches to treat cancer. It also focuses on the use of intravenous immunoglobulin derived from human plasma provided by healthy donors to treat melanoma, prostate, and colon cancers. The company was founded on October 6, 1998 and is headquartered in Kiryat Ono, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Limor Zur-Stoller
